According to the Zhitong Finance App, Guanhao Biotech (300238.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved revenue of 175 million yuan, a year-on-year decrease of 13.12%. Net profit attributable to shareholders of listed companies was 13.2398 million yuan, a year-on-year decrease of 35.11%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 10.423,800, a year-on-year decrease of 47.36%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.